Literature DB >> 23955065

Changing incidence of orthopedic surgery in rheumatic disease: contributing factors.

Elana J Bernstein1, Lisa A Mandl.   

Abstract

Rheumatic diseases are multisystem conditions that predominantly affect the musculoskeletal system, leading to soft tissue and articular damage. Historically, medical therapy was able to slow, but not prevent, erosion and joint destruction, resulting in the frequent need for orthopedic procedures to maintain function and minimize pain. However, the widespread use of disease-modifying anti-rheumatic drugs (DMARDs) and biologic therapy over the last twenty years has resulted in a dramatic decrease in the incidence of musculoskeletal damage and impairment among these patients. This review will discuss changing patterns of orthopedic surgery among patients with rheumatic diseases, focusing on rheumatoid arthritis and systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23955065     DOI: 10.1007/s11926-013-0365-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  87 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Changes in surgical intervention patterns in rheumatoid arthritis over 10 years in one centre.

Authors:  C Kolling; D B Herren; B R Simmen; J Goldhahn
Journal:  Ann Rheum Dis       Date:  2009-08       Impact factor: 19.103

3.  Change in operative workload for rheumatoid disease of the hand: 1,109 procedures over 13 years.

Authors:  M Dafydd; I S Whitaker; M S Murison; D E Boyce
Journal:  J Plast Reconstr Aesthet Surg       Date:  2011-12-17       Impact factor: 2.740

4.  The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991.

Authors:  M Shbeeb; K M Uramoto; L E Gibson; W M O'Fallon; S E Gabriel
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

5.  The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

Authors:  Ferdinand C Breedveld; Michael H Weisman; Arthur F Kavanaugh; Stanley B Cohen; Karel Pavelka; Ronald van Vollenhoven; John Sharp; John L Perez; George T Spencer-Green
Journal:  Arthritis Rheum       Date:  2006-01

6.  Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus.

Authors:  Patricia Katz; Steven Gregorich; Jinoos Yazdany; Laura Trupin; Laura Julian; Edward Yelin; Lindsey A Criswell
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-02       Impact factor: 4.794

7.  Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study.

Authors:  M E Weinblatt; H Kaplan; B F Germain; S Block; S D Solomon; R C Merriman; F Wolfe; B Wall; L Anderson; E Gall
Journal:  Arthritis Rheum       Date:  1994-10

8.  Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.

Authors:  Paul Emery; Ferdinand C Breedveld; Stephen Hall; Patrick Durez; David J Chang; Deborah Robertson; Amitabh Singh; Ronald D Pedersen; Andrew S Koenig; Bruce Freundlich
Journal:  Lancet       Date:  2008-07-16       Impact factor: 79.321

9.  Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987-1989.

Authors:  C E Dugowson; T D Koepsell; L F Voigt; L Bley; J L Nelson; J R Daling
Journal:  Arthritis Rheum       Date:  1991-12

10.  Juvenile idiopathic arthritis in adulthood and orthopaedic intervention.

Authors:  Ajay Malviya; Sarah Johnson-Lynn; Peter Avery; David Deehan; Helen Foster
Journal:  Clin Rheumatol       Date:  2009-08-30       Impact factor: 2.980

View more
  2 in total

Review 1.  Altering the natural history of rheumatoid arthritis: The role of immunotherapy and biologics in orthopaedic care.

Authors:  Steven J Girdler; Ivan Ye; Ray Tang; Noah Kirschner
Journal:  J Orthop       Date:  2019-07-01

2.  The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank.

Authors:  James Dale; Caron Paterson; Ann Tierney; Stuart H Ralston; David M Reid; Neil Basu; John Harvie; Neil D McKay; Sarah Saunders; Hilary Wilson; Robin Munro; Ruth Richmond; Derek Baxter; Michael McMahon; John McLaren; Vinod Kumar; Stefan Siebert; Iain McInnes; Duncan Porter
Journal:  BMC Musculoskelet Disord       Date:  2016-11-09       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.